Clinical Trials Browser

NIH × Trimethoprim, Sulfamethoxazole Drug Combination × Clear all

NCT00061945 2022-05-03

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Phase 1/2 Completed

302 enrolled 11 charts

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00004216 2013-07-18

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific